Multiple (NSCLC, Melanoma, Colorectal) Cancers - Ph1b/2 Dose-Escalation Study of Entinostat With Pembrolizumab in NSCLC With Expansion Cohorts in NSCLC and Melanoma

The purpose of this study is to determine the safety and tolerability of entinostat used in combination with pembrolizumab in patients with Non-small Cell Lung Cancer. Additionally the purpose of the study is to assess how effective entinostat and pembrolizumab are in combination in patients with Non-small Cell Lung Cancer and Melanoma.

Learn more at Clinicaltrials.gove NCT2437136

Cancer, Adult Lung Cancer, Adult Multiple/Other Cancers, Adult Gastrointestinal Cancer